← 產業報告目錄
Pharmaceutical Manufacturing Software Market Size, Share & Trends Analysis Distribution by Deployment Type (On-cloud, On-premise), Application (Large Enterprises, Small and Midsize Enterprises), End User (Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations, Academic Research Institutions) and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-24頁數 172報告編號 INSIGHTACE-8437a077f2
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Pharmaceutical Manufacturing Software Market stood at USD 2.9 Bn in 2023, and is poised to reach USD 5.5 Bn by 2031, recording a CAGR of 8.6% from 2024 through 2031.
Pharmaceutical Manufacturing Software covers is the backbone of the pharmaceutical industry because it helps to streamline and ensures the processes go in line with such rigid regulatory standards. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharmaceutical Manufacturing Software Market Snapshot
Chapter 4. Global Pharmaceutical Manufacturing Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Pharmaceutical Manufacturing Software Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Pharmaceutical Manufacturing Software Industry Trends
Chapter 5. Pharmaceutical Manufacturing Software Market Segmentation 1: By Deployment Type, Estimates & Trend Analysis
5.1. Market Share by Deployment Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Deployment Type:
5.2.1. On-cloud
5.2.2. On-premise
Chapter 6. Pharmaceutical Manufacturing Software Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Large Enterprises
6.2.2. Small and Midsize Enterprises
Chapter 7. Pharmaceutical Manufacturing Software Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End User:
7.2.1. Biopharmaceutical Companies
7.2.2. Medical Device Companies
7.2.3. Contract Research Organizations
7.2.4. Academic Research Institutions
7.2.5. Others
Chapter 8. Pharmaceutical Manufacturing Software Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Pharmaceutical Manufacturing Software Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2024-2031
8.2.3. North America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. North America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.3. Europe
8.3.1. Europe Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2024-2031
8.3.3. Europe Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Europe Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2024-2031
8.4.3. Asia Pacific Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Asia Pacific Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.5. Latin America
8.5.1. Latin America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2024-2031
8.5.3. Latin America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Latin America Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2024-2031
8.6.3. Middle East & Africa Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.6.4. Middle East & Africa Pharmaceutical Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Oracle Corporation
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial PerApplicationance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Pegasystems Inc
9.2.3. MasterControl Inc.
9.2.4. Veeva Systems Inc
9.2.5. Siemens AG
9.2.6. Honeywell International Inc
9.2.7. Werum IT Solutions GmbH
9.2.8. Dassault Systèmes
9.2.9. Emerson Electric Co
9.2.10. Rockwell Automation Inc.
9.2.11. Parsec Automation Corp
9.2.12. ABB Ltd
9.2.13. Aspen Technology Inc
9.2.14. Schneider Electric SE
9.2.15. Körber AG
9.2.16. Sparta Systems Inc.
9.2.17. QAD Inc.
9.2.18. Kinaxis Inc.
9.2.19. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們